BNP
BNP is an intervention with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Access BNP Clinical Performance Evaluation: Testing and Clinical Concordance Study
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease
Access BNP Clinical Enrollment Study
Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis
Clinical Trials (8)
Access BNP Clinical Performance Evaluation: Testing and Clinical Concordance Study
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease
Access BNP Clinical Enrollment Study
Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis
Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction
A Sunscreen Based on Bioadhesive Nanoparticles
Brain Natriuretic Peptide Effects on Appetite Regulating Hormones and Endothelial Derived Peptides
All 8 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 8